Skip to main content
. 2017 Aug 3;8(47):83334–83342. doi: 10.18632/oncotarget.19833

Table 3. Non-hormonal benefits of combined hormonal contraceptives with the progestogens dienogest and drospirenone.

Modified from Schindler [41].

1.) Menstrual bleeding disorders
2.) Dysmenorrhea
3.) Premenstrual syndrome/premenstrual dysphoric disorders
4.) Signs of androgenization
5.) Ovarian cysts
6.) Pelvic inflammatory diseases (PID)
7.) Rheumatoid arthritis
8.) Preservation of bone density
9.) Endometriosis/adenomyosis
10.) Uterine myoma
11.) Benign breast diseases
12.) Ovarian cancer
13.) Endometrial cancer
14.) Colon cancer